Actively Recruiting
Multimodal Biocollection Linked to the French Register of Intracranial Aneurysms
Led by Nantes University Hospital · Updated on 2026-05-29
1100
Participants Needed
26
Research Sites
N/A
Total Duration
On this page
Sponsors
N
Nantes University Hospital
Lead Sponsor
F
Federation of Medical Specialties
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are collecting detailed data and human samples linked to the French Intracranial Aneurysm Registry to improve understanding and management of intracranial aneurysms (ICA). The study aims to better classify ICA cases by combining genetic, imaging, and rupture information. This approach may help identify specific subgroups for improved diagnosis and risk assessment in both familial and general populations. Participants include adults with confirmed typical bifurcation ICAs verified by MRI or cerebral arteriography. The study gathers genetic mutation data, imaging of aneurysm and vascular structures, and clinical information. Blood or saliva samples are collected to support this data collection. The study includes both sporadic cases and families with multiple affected members, with screening using MRI and Time of Flight sequences. Participants will undergo imaging assessments and provide biological samples, with data collected over 36 months to develop a predictive model for ICA subtypes. Researchers will study arterial bifurcations, aneurysm characteristics, genetic mutations, and genotype-phenotype relationships. The study includes consent procedures and ensures participants are covered by social security. Safety monitoring excludes those with MRI contraindications, and participation involves ongoing data collection and evaluation.
CONDITIONS
Brief Title
Multimodal Biocollection Linked to the French Register of Intracranial Aneurysms
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults with a confirmed typical bifurcation intracranial aneurysm verified by MRI and/or cerebral arteriography
- Aneurysm discovered less than a year ago with initial imaging available
- Written consent obtained for study participation
- Patient covered by a social security plan
- For familial cases: index patients with at least one related family member affected, and adult family relatives with MRI screening
- Written consent and social security coverage for family participants
You will not qualify if you...
- Known syndromic diagnoses causing intracranial aneurysms such as Marfan syndrome, Ehlers Danlos syndrome type II and IV, Moya-Moya syndrome, SMAD3-related obstructive sleep apnea, or Autosomal Dominant Cystic Fibrosis
- Aneurysms that are dissecting, fusiform, associated with arteriovenous malformation, blister-like, or mycotic
- Cerebral white matter pathology on MRI suggesting Col4a1 mutation
- Patients under guardianship, conservatorship, or court protection
- Contraindication to MRI scan
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 36 months
Participants provide blood or saliva samples for genetic and biological analysis.
Trial Site Locations
Total: 26 locations
1
Nantes University Hospital
Nantes, Loire-Atlantique, France, 44093
Actively Recruiting
2
CHU Amiens
Amiens, France
Not Yet Recruiting
3
CHU Angers
Angers, France
Not Yet Recruiting
4
CHU Besançon
Besançon, France
Not Yet Recruiting
5
CHU Bordeaux Hôpital Pellegrin
Bordeaux, France
Not Yet Recruiting
6
CHU de Brest
Brest, France
Not Yet Recruiting
7
CHU Caen-Normandie
Caen, France
Not Yet Recruiting
8
CHU Clermont-Ferrand
Clermont-Ferrand, France, 63000
Actively Recruiting
9
CHU Limoges
Limoges, France
Not Yet Recruiting
10
APHM
Marseille, France
Not Yet Recruiting
11
CHU de Montpellier
Montpellier, France
Not Yet Recruiting
12
CHRU de Nancy
Nancy, France
Not Yet Recruiting
13
GHU Paris - Hôpital Ste Anne
Paris, France
Not Yet Recruiting
14
Hôpital Fondation Rothschild
Paris, France
Not Yet Recruiting
15
Hôpital La Pitié Salpêtrière
Paris, France
Not Yet Recruiting
16
Hôpital Lariboisière
Paris, France
Not Yet Recruiting
17
CHU de Poitiers
Poitiers, France
Not Yet Recruiting
18
CHU de Reims
Reims, France
Not Yet Recruiting
19
CHU Rennes
Rennes, France
Not Yet Recruiting
20
CHU de Rouen
Rouen, France
Not Yet Recruiting
21
CHU St Etienne
Saint-Etienne, France
Not Yet Recruiting
22
Hôpitaux Universitaires de Strasbourg
Strasbourg, France
Not Yet Recruiting
23
Hôpital Foch
Suresnes, France
Not Yet Recruiting
24
HIA Sainte-Anne
Toulon, France
Not Yet Recruiting
25
CHU de Toulouse
Toulouse, France
Not Yet Recruiting
26
CHRU Tours Hôpital Bretonneau
Tours, France
Not Yet Recruiting
Research Team
R
Romain BOURCIER, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here